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SS21.
Future of Vascular Surgery is in the Office
Krishna Jain, John S Munn, Mark C Rummel, Sarat K Vaddineni, Chris D
Longton. Advanced Vascular Surgery, kalamazoo, MI
Objective: The Practice of Vascular Surgery is under pressure from
various specialties and payers. Our group started office based procedures in
May of 2007. The purpose of this paper is to study the impact of this change
on our case volume, office revenue and the financial impact on healthcare
system.
Methods: Between 5/1/06 and 4/30/07 (Period1) and between
6/1/07 and 5/31/08 (Period 2), total of 3041 and 3351 cases were
performed respectively. In Period 1 only venous cases could be done in the
office. Prior to arteriogram BUN and Creatinine level is obtained. The
number of percutaneous cases done in hospital and office setting were
analyzed and revenue was calculated based on the 2008 Medicare fee
schedule for our region. Thirty day amputation rate and mortality was
documented. Hospital DRG payment schedule was obtained.
Results: In Period 1, 670 (22% of total) percutaneous procedures were
performed as compared to 1502 (44.8%) in Period 2, a two fold increase. In
Period1, 1.5% of total cases were done in office as compared to 31% in Period
2. There was a fivefold increase in revenue from these procedures. There was
no mortality or amputation as a result of procedures performed in office.
There was no anesthesiologist’s expense and minimal pre-procedure ex-
pense. Total payment byMedicare, DRG payment to hospital plus physician
component is higher in all the cases.
Procedure
Period1 Period1 Period2 Period2 R/C R/C Hosp.
Hospital Office Hospital Office Hospital Office DRG
Cath Ins. 198 240 146 $ 309 $ 947 $ 1581
Cath Rem 62 38 122 $ 134 $ 160 $ 361
Fist Thro 71 29 113 $ 426 $2,232 $2,655
Fist Angio 94 28 238 $ 460 $2,450 $2,977
Fist Stent 1 5 9 $ 605 $4,900 $5,808
Fist coil 22 $1,170 $2,407 $5,741
Fist 8 11 47 $ 183 $ 633 $ 613
Aor Angio 16 48 33 $ 589 $3,854 $2,977
Aor Run 114 47 104 $ 267 $1,397 $1,895
Aor Stent 7 18 11 $ 719 $5,860 $5,808
Aorta 18 12 $ 204 $1,003 $1,895
EVLT 38 40 132 $ 324 $1,539 $1,695
Micro 13 4 19 $ 423 $ 423 $1,695
Venogram 4 4 8 $ 208 $1,079 $1,895
Total 626 44 486 1016
Key: Cath-Catheter, Ins-Insert, Fist-Fistulogram, Thro-Thrombectomy,
Angio-Angioplasty, Aor-Aortogram, Run-runoff, EVLT-Endovenous laser
Therapy, Micro-Microphlebectomy, R/C-Revenue per case.
Conclusions: AVascular Surgery practice can benefit from office based
procedures. Procedures can be done safely. It results in an increase in
number of percutaneous procedures and revenue. There are significant
savings to health care system. Surgeons can control their schedule. Every
vascular surgeon should consider doing these procedures in office.Author Disclosures: K. Jain, None; J.S. Munn, None; M.C. Rummel,
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SS22.
Totally Laparoscopic Aortic Surgery: Experience In A French Academic
Center
Jérôme Cau, Jean-Baptiste Ricco. Poitiers University Hospital, Poitiers,
France
Background: The application of laparoscopic techniques for vascular
procedures has been limited by factors such as difficulties in aortic exposure
and anastomosis techniques, as well as the concurrent competitive progress
of endovascular surgery. The purpose of this study was to review the
outcomes for laparoscopic aortic interventions in the endovascular era.
Methods: Retrospective analysis was carried out for a series of 219
patients who underwent a totally laparoscopic aortic procedure for treat-
ment of aortic occlusive disease (AOD; n 127) or abdominal aortic
aneurysm (AAA; n80) and 12 aorto-renal bypass. This series did not
include patients operated in others centers (110 aortic bypasses).
Findings: Mean patient age was 61 years and the sex ratio was 3 men
for 1 woman. The mean operative time of procedures for AOD was 223
/ 50 minutes, with a mean clamp time of 56 / 21 minutes. 3.6% of
the AOD procedures had to be converted to open. For laparoscopic AAA
procedures, the mean operative time was 262 / 57 minutes and the
mean clamp time was 103 / 15 minutes. 8 conversions (10%) to open
procedure had to be performed in this subgroup. The 30-day mortality rate
was 0.9%. Overall mortality rate was 13.4% during a mean follow-up time of
16.2 months. The primary patency rate was 100%.
Conclusions:Totally laparoscopic aortic surgery is feasible and showed
promising and satisfactory results in our experience. Precise indications for
this kind of surgery, compared to endovascular and open surgery, remain to
be determined by randomized studies. Nevertheless, it is a difficult tech-
nique. Further development will rely on effective training, advances in
technique and instrumentation.
Author Disclosures: J. Cau, None; J. Ricco, None.
SS23.
The Incidence of Infectious Complications After Elective Vascular
Surgery in the United States
Todd R Vogel, Viktor Y Dombrovskiy, Jeffrey L Carson, Paul B Haser,
Stephen F Lowry, Alan M Graham. UMDNJ-Robert Wood Johnson Med-
ical School, New Brunswick, NJ
Objective: To evaluate the incidence and socio-demographics of post-
operative infectious complications after elective vascular surgery, to define
vascular procedures with the greatest risk of developing nosocomial infec-
tions, and to assess the impact of infection on utilization.
Methods:TheNationwide Inpatient Sample (2002-2006) was utilized
to identify major vascular procedures by ICD-9-CM codes. Infectious
complications including pneumonia (PNA), urinary tract infections (UTI),
postoperative sepsis, and surgical site infections (SSI) were identified. Case
mix-adjusted rates for age, race, gender, and comorbidities were calculated
using a multivariate logistic regression model with infectious complications
as an outcome.
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Volume 49, Number 5S Plenary Sessions 9SResults: 870,778 elective vascular surgical procedures were evaluated
with an overall infection rate of 3.70%. Open abdominal aortic surgery had
the greatest rate of postoperative infections compared to open thoracic and
aorta-iliac-femoral bypass surgeries. Thoracic endografting infectious com-
plication rates were two times greater than EVAR (P.0001). PNA was the
most common infectious complication after open aortic surgery (6.63%)
where UTI was the most common after TEVAR (2.86%) and EVAR
(1.31%). Infectious complications were greater in octogenarians (p.0002),
women (P.0001), and blacks (P.0001 compared to whites and Hispan-
ics). Nosocomial infections significantly increased length of stay (days) and
charges (13.815.4 vs. 3.54.2; $37,83442,905 vs. $11,85111,816,
respectively, p0.001).
Conclusions:Among elective vascular surgical procedures, open aortic
surgery and CEA have, respectively, the greatest and the least risk for
postoperative infectious complications. Women, octogenarians, and blacks
have the highest risk of infectious complications after elective vascular
surgery. Hospital infectious complications dramatically increase resource






1. Endarterectomy; vessel of
head and neck
1.66 1.65 - 1.67
2. Open Abdominal Aortic
resection or replacement
11.35 11.19 - 11.51
3. Open Thoracic and
Thoracoabdominal Repair
11.29 11.07 - 11.52
4. Endovascular Abdominal
Aneurysm Repair (EVAR)
2.84 2.81 - 2.87
5. Thoracic Endovascular
Aneurysm Repair (TEVAR)
5.73 5.34 - 6.12
6. Aorta-iliac-femoral bypass 8.94 8.81 - 9.07
7. Peripheral vascular bypass 4.19 4.15 - 4.23
8. Embolectomy and
endarterectomy of lower limb
4.63 4.56 - 4.70
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SS24.
The Diagnosis Of Claudication Is Influenced By Patients’ Sex
Birgitta M Sigvant, Sr.1,2. 1Karlstad, Sweden; 2Inst of Molecular Medicine
and Surgery, Karolinska University Hospital, Stockholm, Sweden
Objectives: PAD afflicts 18% of the elderly and the prevalence varies
with PAD stage and patients’ sex. Women, for instance, dominate when
diagnosis is based on ABI only, but for intermittent claudication (IC) that
requires a subjective component the prevalence is higher among men. The
purposes of this study was to evaluate if utilization of common diagnostic
criteria for IC results in dissimilar types of IC for women and men and also
to identify any possible difference in perception of IC symptoms between the
sexes.
Methods: Eight thousand women and men, aged 59-89 years, were
selected at random and invited to participate. The 5040 subjects who
accepted had ABI measured and completed questionnaires covering medical
history, current medication, PAD symptoms and walking ability. A subset of
subjects with IC at that time was followed up using the same questionnaires
and also performed a walking test, underwent duplex scanning of leg
arteries, ABI assessment and echocardiography. They were also interviewed
in detail about their symptoms.
Results: The point-prevalence of IC was 6.5% for women and 7.2% for
men (P.09) in the cohort and the mean ABI among IC subjects was 0.7
(SD 0.2). A fifth (19%) of women with IC had ABI0.5 compared to 7% for
men. Men with IC reported having DM, stroke and a smoking history more
often than women, who in turn reported hypertension more frequently.
Women with IC had problems with a lower (P0.01) walking speed
(P0.01) more often than men, and a larger proportion of them experi-
enced joint problems (P0.018) and heart palpitations (P0.002)
Conclusions: In this study the prevalence of IC tended to be more
common among men using classic IC definitions, but this may be a conse-
quence of sex differences in presentation of symptoms. Accordingly, ICprevalence and consequences of IC may be underestimated in women and
this needs to be considered when assessing IC in epidemiological studies,
clinical trials and as indication for revascularization.
SS25.
Cryopreserved Venous Allograft: An Alternative Conduit for Recon-
struction of Infected Prosthetic Aortic Grafts
Jason N MacTaggart, Thomas S Monahan, Jade S Hiramoto, Timothy AM
Chuter, Darren B Schneider, Rajabrata Sarkar, Charles M Eichler, Joe H
Rapp, Michael S Conte, Linda M Reilly. University of California San
Francisco, San Francisco, CA
Objective: To evaluate the performance of cryopreserved superficial
femoral vein (cryoSFV) for in-line aortic reconstruction of infected pros-
thetic aortic grafts (IPAG).
Methods: Retrospective, single institution review of patients undergo-
ing in-line cryoSFV reconstruction after removal of IPAG. Follow up
survival, limb preservation and re-intervention data were available for 85% of
patients surviving 30 days.
Results: From 1999 to 2008, 40 patients with IPAG (mean age 68,
65% men, 75% aortic occlusive disease, 43% with aortoenteric fistulas)
underwent complete aortic graft excision and in-line aortic reconstruction,
with an infrarenal aorta-to-cryoSFV anastomosis in 37 (93%). 30-day mor-
tality was 15% (3 cardiac, 3 infectious). During follow-up (mean 30months)
no deaths resulted from the aortic graft infection or its treatment. 1 patient
(3%) required amputation. 4/6 early re-interventions were for anastomotic
or conduit bleeding (including 2/3 perioperative deaths due to persistent
infection). 5/8 late re-interventions were for aneurysmal degeneration of
the cryovein (mean interval 32 months and 4/5 involving the femoral
conduit segment). Kaplan-Meier 36-month cure rate was 80% and re-
intervention-free survival was 68%.
Conclusions: Cryopreserved superficial femoral vein is a suitable con-
duit for in-line aortic reconstruction after removal of IPAG. Survival and
limb salvage rates rival those reported for all other treatment methods.
CryoSFV is more resistant to infection than prosthetic repair, eliminates the
complications of autologous vein harvest and is immediately available for use
off the shelf. However the conduit demonstrates late aneurysmal degenera-
tion and extended follow up is needed.
Author Disclosures: J.N. MacTaggart, None; T.S. Monahan, None; J.S.
Hiramoto, None; T.A. Chuter, Cook; D.B. Schneider, Gore, Cook; R.
Sarkar,None;C.M. Eichler,None; J.H. Rapp,None;M.S. Conte,None;
L.M. Reilly, None.
SS26.
Contemporary Management of Vascular Complications Associated
with Ehlers-Danlos Syndrome
Benjamin S Brooke1, Nazli B McDonnell2, James H Black, III1. 1Johns
Hopkins Hospital, Baltimore, MD; 2National Institutes of Health, Balti-
more, MD
Objectives: There has been debate regarding the safety of performing
elective procedures in patients with vascular manifestations associated with
Ehlers-Danlos Syndrome (EDS). The purpose of this study was to review the
surgical management and clinical outcomes of EDS patients at a tertiary
medical center with multimodality expertise in connective tissue disorders.Methods: All patients with EDS undergoing elective treatment at a
single institution academic medical center from 1994 to 2008 were retro-
